Special Investigation For Long Term Use Of Detrusitol (Regulatory Post Marketing Commitment Plan).
Phase of Trial: Phase IV
Latest Information Update: 06 Jul 2012
At a glance
- Drugs Tolterodine (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
- 06 Jul 2012 Primary endpoint amended and actual patient number change from 9 to 374 reported by ClinicalTrials.gov
- 07 Jun 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
- 07 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.